MRNA transfection-based, feeder-free, induced pluripotent stem cells derived from adipose tissue of a 50-year-old patient

Metabolic Engineering

Volumn 18, Issue , 2013, Pages 9-24

  Heng, Boon Chin ^a   Heinimann, Karl ^b   Miny, Peter ^c   Iezzi, Giandomenica ^d   Glatz, Katharina ^d   Scherberich, Arnaud ^d   Zulewski, Henryk ^a,d   Fussenegger, Martin ^a,b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Adipose; Feeder free; Induced; MRNA; Pluripotent; Stem cells; Transfection

Indexed keywords

ADIPOSE; FEEDER-FREE; INDUCED; MRNA; PLURIPOTENT; TRANSFECTION;

CELL CULTURE; CHROMOSOMES; CLONE CELLS; FEEDING; FLOW CYTOMETRY; GENETIC ENGINEERING; POLYMERASE CHAIN REACTION; RNA; STEM CELLS; TISSUE; TRANSCRIPTION FACTORS;

MOLECULAR BIOLOGY;

MESSENGER RNA; RECOMBINANT DNA; VIRUS VECTOR;

ADIPOSE TISSUE; ADULT; ARTICLE; CASE REPORT; CELL CULTURE; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KARYOTYPE 46,XX; MESENCHYMAL STEM CELL; MOSAICISM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; RNA, MESSENGER; TRANSFECTION;

EID: 84877130503     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2013.02.004     Document Type: Article

References (64)

1. Baer P.C., Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int. 2012, 2012:812693.
2. Baker D.E., Harrison N.J., Maltby E., Smith K., Moore H.D., Shaw P.J., Heath P.R., Holden H., Andrews P.W. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 2007, 25:207-215.
3. Banito A., Rashid S.T., Acosta J.C., Li S., Pereira C.F. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 2009, 23:2134-2139.
4. Ben-David U., Mayshar Y., Benvenisty N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell 2011, 9:97-102.
5. Bergström R., Ström S., Holm F., Feki A., Hovatta O. Xeno-free culture of human pluripotent stem cells. Methods Mol. Biol. 2011, 767:125-136.
6. Bianco C., Rangel M.C., Castro N.P., Nagaoka T., Rollman K., Gonzales M., Salomon D.S. Role of Cripto-1 in stem cell maintenance and malignant progression. Am. J. Pathol. 2010, 177:532-540.
7. Braam S.R., Zeinstra L., Litjens S., Ward-van Oostwaard D., van den Brink S., van Laake L., Lebrin F., Kats P., Hoch-stenbach F. Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells 2008, 26:2257-2265.
8. Brafman D.A., Chang C.W., Fernandez A., Willert K., Varghese S., Chien S. Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials 2010, 31:9135-9144.
9. Bunnell B.A., Flaat M., Gagliardi C., Patel B., Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 2008, 45:115-120.
10. Burger S.R. Current regulatory issues in cell and tissue therapy. Cytotherapy 2003, 5:289-298.
11. Butler J.M. Genetics and genomics of core short tandem repeat loci used in human identity testing. J. Forensic Sci. 2006, 51:253-265.
12. Chan E.M., Ratanasirintrawoot S., Park I.H., Manos P.D., Loh Y.H., Huo H., Miller J.D., Hartung O., Rho J., Ince T.A., Daley G.Q., Schlaeger T.M. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 2009, 27:1033-1037.
13. Chen A.K., Chen X., Choo A.B., Reuveny S., Oh S.K. Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res. 2011, 7:97-111.
14. Derda R., Musah S., Orner B.P., Klim J.R., Li L., Kiessling L.L. High-throughput discovery of synthetic surfaces that support proliferation of pluripotent cells. J. Am. Chem. Soc. 2010, 132:1289-1295.
15. Drews K., Tavernier G., Demeester J., Lehrach H., De Smedt S.C., Rejman J., Adjaye J. The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts. Biomaterials 2012, 33:4059-4068.
16. Feng B., Ng J.H., Heng J.C., Ng H.H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 2009, 4:301-312.
17. Gauthaman K., Fong C.Y., Bongso A. Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: its benefits in hESC expansion. Stem Cell Rev. 2010, 6:86-95.
18. Gore A., Li Z., Fung H.L., Young J.E., Agarwal S., Antosiewicz-Bourget J., Canto I., Giorgetti A., Israel M.A., Kiskinis E., Lee J.H, Loh Y.H., Manos P.D., Montserrat N., Panopoulos A.D., Ruiz S., Wilbert M.L., Yu J., Kirkness E.F., Izpisua Belmonte J.C., Rossi D.J., Thomson J.A., Eggan K., Daley G.Q., Goldstein L.S., Zhang K. Somatic coding mutations in human induced pluripotent stem cells. Nature 2003, 471:63-67.
19. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M.P., Wulffraat N., Leboulch P., Lim A., Osborne C.S., Pawliuk R., Morillon E., Sorensen R., Forster A., Fraser P., Cohen J.I., de Saint Basile G., Alexander I., Wintergerst U., Frebourg T., Aurias A., Stoppa-Lyonnet D., Romana S., Radford-Weiss I., Gross F., Valensi F., Delabesse E., Macintyre E., Sigaux F., Soulier J., Leiva L.E., Wissler M., Prinz C., Rabbitts T.H., Le Deist F., Fischer A., Cavazzana-Calvo M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003, 302:415-419.
20. Hao J., Sawyer D.B., Hatzopoulos A.K., Hong C.C. Recent progress on chemical biology of pluripotent stem cell self-renewal, reprogramming and cardiomyogenesis. Recent Pat. Regen. Med. 2011, 1:263-274.
21. Hoss M., Sarić T., Denecke B., Peinkofer G., Bovi M., Groll J., Ko K., Salber J., Halbach M., Schöler H.R., Zenke M., Neuss S. Expansion and differentiation of germline-derived pluripotent stem cells on biomaterials. Tissue Eng. Part A 2013, 19:1067-1080.
22. Hussein S.M., Batada N.N., Vuoristo S., Ching R.W., Autio R., Närvä E., Ng S., Sourour M., Hämäläinen R., Olsson C., Lundin K., Mikkola M., Trokovic R., Peitz M., Brüstle O., Bazett-Jones D.P., Alitalo K., Lahesmaa R., Nagy A., Otonkoski T. Copy number variation and selection during reprogramming to pluripotency. Nature 2011, 471:58-62.
23. Hwang S.T., Kang S.W., Lee S.J., Lee T.H., Suh W., Shim S.H., Lee D.R., Taite L.J., Kim K.S., Lee S.H. The expansion of human ES and iPS cells on porous membranes and proliferating human adipose-derived feeder cells. Biomaterials 2010, 31:8012-8021.
24. Jin S., Yao H., Weber J.L., Melkoumian Z.K., Ye K. A synthetic, xeno-free peptide surface for expansion and directed differentiation of human induced pluripotent stem cells. PLoS One 2012, 7:e50880.
25. Kadaja M., Isok-Paas H., Laos T., Ustav E., Ustav M. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog. 2009, 5:e1000397.
26. Kawamura T., Suzuki J., Wang Y.V., Menendez S., Morera L.B. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009, 460:1140-1144.
27. Kim D., Kim C.H., Moon J.I., Chung Y.G., Chang M.Y., Han B.S., Ko S., Yang E., Cha K.Y., Lanza R., Kim K.S. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
28. Kim S.K., Suh M.R., Yoon H.S., Lee J.B., Oh S.K., Moon S.Y., Moon S.H., Lee J.Y., Hwang J.H., Cho W.J., Kim K.S. Identification of developmental pluripotency associated 5 expression in human pluripotent stem cells. Stem Cells 2005, 23:458-462.
29. Klim J.R., Li L., Wrighton P.J., Piekarczyk M.S., Kiessling L.L. A defined glycosaminoglycan-binding substratum for human pluripotent stem cells. Nat. Methods 2010, 7:989-994.
30. Kolhar P., Kotamraju V.R., Hikita S.T., Clegg D.O., Ruoslahti E. Synthetic surfaces for human embryonic stem cell culture. J. Biotechnol. 2010, 146:143-146.
31. Lapasset L., Milhavet O., Prieur A., Besnard E., Babled A. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 2011, 25:2248-2253.
32. Laurent L.C., Ulitsky I., Slavin I., Tran H., Schork A., Morey R., Lynch C., Harness J.V., Lee S., Barrero M.J., Ku S., Martynova M., Semechkin R., Galat V., Gottesfeld J., Izpisua Belmonte J.C., Murry C., Keirstead H.S., Park H.S., Schmidt U., Laslett A.L., Muller F.J., Nievergelt C.M., Shamir R., Loring J.F. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011, 8:106-118.
33. Levenstein M.E., Ludwig T.E., Xu R.H., Llanas R.A., VanDenHeuvel-Kramer K., Manning D., Thomson J.A. Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells 2006, 24:568-574.
34. Li H., Collado M., Villasante A., Strati K., Ortega S. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009, 460:1136-1139.
35. Li R., Liang J., Ni S., Zhou T., Qing X., Li H., He W., Chen J., Li F., Zhuang Q., Qin B., Xu J., Li W., Yang J., Gan Y., Qin D., Feng S., Song H., Yang D., Zhang B., Zeng L., Lai L., Esteban M.A., Pei D. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010, 7:51-63.
36. Lin K., Matsubara Y., Masuda Y., Togashi K., Ohno T., Tamura T., Toyoshima Y., Sugimachi K., Toyoda M., Marc H., Douglas A. Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Cytotherapy 2008, 10:417-426.
37. Lin T., Ambasudhan R., Yuan X., Li W., Hilcove S., Abujarour R., Lin X., Hahm H.S., Hao E., Hayek A., Ding S. A chemical platform for improved induction of human iPSCs. Nat. Methods 2009, 6:805-808.
38. Lister R., Pelizzola M., Kida Y.S., Hawkins R.D., Nery J.R., Hon G., Antosiewicz-Bourget J., O'Malley R., Castanon R., Klugman S., Downes M., Yu R., Stewart R., Ren B., Thomson J.A., Evans R.M., Ecker J.R. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011, 471:68-73.
39. Marion R.M., Strati K., Li H., Tejera A., Schoeftner S. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009, 4:141-154.
40. Mathew R., Jia W., Sharma A., Zhao Y., Clarke L.E., Cheng X., Wang H., Salli U., Vrana K.E., Robertson G.P., Zhu J., Wang S. Robust activation of the human but not mouse telomerase gene during the induction of pluripotency. FASEB J. 2010, 24:2702-2715.
41. Mayshar Y., Ben-David U., Lavon N., Biancotti J.C., Yakir B., Clark A.T., Plath K., Lowry W.E., Benvenisty N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010, 7:521-531.
42. Meisner L.F., Johnson J.A. Protocols for cytogenetic studies of human embryonic stem cells. Methods 2008, 45:133-141.
43. Miyoshi N., Ishii H., Nagano H., Haraguchi N., Dewi D.L., Kano Y., Nishikawa S., Tanemura M., Mimori K., Tanaka F., Saito T., Nishimura J., Takemasa I., Mizushima T., Ikeda M., Yamamoto H., Sekimoto M., Doki Y., Mori M. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 2011, 8:633-638.
44. Mostoslavsky G. Concise review: the magic act of generating induced pluripotent stem cells: many rabbits in the hat. Stem Cells 2012, 30:28-32.
45. Oh S.K., Chen A.K., Mok Y., Chen X., Lim U.M., Chin A., Choo A.B., Reuveny S. Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res. 2009, 2:219-230.
46. Ohnishi H., Oda Y., Aoki T., Tadokoro M., Katsube Y., Ohgushi H., Hattori K., Yuba S. A comparative study of induced pluripotent stem cells generated from frozen, stocked bone marrow- and adipose tissue-derived mesenchymal stem cells. J. Tissue Eng. Regen. Med. 2012, 6:261-271.
47. Prokhorova T.A., Harkness L.M., Frandsen U., Ditzel N., Schrøder H.D., Burns J.S., Kassem M. Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. Stem Cells Dev. 2009, 18:47-54.
48. Prowse A.B., Doran M.R., Cooper-White J.J., Chong F., Munro T.P., Fitzpatrick J., Chung T.L., Haylock D.N., Gray P.P., Wolvetang E.J. Long term culture of human embryonic stem cells on recombinant vitronectin in ascorbate free media. Biomaterials 2010, 31:8281-8288.
49. Samavarchi-Tehrani P., Golipour A., David L., Sung H.K., Beyer T.A., Datti A., Woltjen K., Nagy A., Wrana J.L. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010, 7:64-77.
50. Schwartz S.D., Hubschman J.P., Heilwell G., Franco-Cardenas V., Pan C.K., Ostrick R.M., Mickunas E., Gay R., Klimanskaya I., Lanza R. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012, 379:713-720.
51. Sidhu K.S. New approaches for the generation of induced pluripotent stem cells. Expert Opin. Biol. Ther. 2011, 11:569-579.
52. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
53. Tavernier G., Wolfrum K., Demeester J., De Smedt S.C., Adjaye J., Rejman J. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc. Biomaterials 2012, 33:412-417.
54. Tokuzawa Y., Kaiho E., Maruyama M., Takahashi K., Mitsui K., Maeda M., Niwa H., Yamanaka S. Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol. Cell Biol. 2003, 23:2699-2708.
55. User Manual: Stemgent mRNA Reprogramming System (updated January 2012): (Date accessed: 12 September 2012). http://assets.stemgent.com/files/977/original/Stemgent_mRNAUserManual_2012.pdf.
56. Utikal J., Polo J.M., Stadtfeld M., Maherali N., Kulalert W. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009, 460:1145-1148.
57. Vuoristo S., Virtanen I., Takkunen M., Palgi J., Kikkawa Y., Rousselle P., Sekiguchi K., Tuuri T., Otonkoski T. Laminin isoforms in human embryonic stem cells: synthesis, receptor usage and growth support. J. Cell. Mol. Med. 2009, 13:2622-2633.
58. Wakao S., Kitada M., Kuroda Y., Shigemoto T., Matsuse D., Akashi H., Tanimura Y., Tsuchiyama K., Kikuchi T., Goda M., Nakahata T., Fujiyoshi Y., Dezawa M. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc. Natl. Acad. Sci. USA 2011, 108:9875-9880.
59. Warren L., Manos P.D., Ahfeldt T., Loh Y.H., Li H., Lau F., Ebina W., Mandal P.K., Smith Z.D., Meissner A., Daley G.Q., Brack A.S., Collins J.J., Cowan C., Schlaeger T.M., Rossi D.J. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7:618-630.
60. Warren L., Ni Y., Wang J., Guo X. Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Sci. Rep. 2012, 2:657.
61. Watanabe K., Ueno M., Kamiya D., Nishiyama A., Matsumura M., Wataya T., Takahashi J.B., Nishikawa S., Nishikawa S., Muguruma K., Sasai Y. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 2007, 25:681-686.
62. Yagi T., Ito D., Okada Y., Akamatsu W., Nihei Y. Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum. Mol. Genet. 2011, 20:4530-4539.
63. Zhang H., Ma Y., Gu J., Liao B., Li J., Wong J., Jin Y. Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors. Biomaterials 2012, 33:5047-5055.
64. Zhou H., Wu S., Joo J.Y., Zhu S., Han D.W., Lin T., Trauger S., Bien G., Yao S., Zhu Y., Siuzdak G., Schöler H.R., Duan L., Ding S. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4:381-384.